Year |
Citation |
Score |
2011 |
Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine. 17: 211-5. PMID 21240262 DOI: 10.1038/Nm.2284 |
0.72 |
|
2010 |
Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, Bader AG. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Research. 70: 5923-30. PMID 20570894 DOI: 10.1158/0008-5472.Can-10-0655 |
0.356 |
|
2010 |
Takeshita F, Patrawala L, Osaki M, Takahashi RU, Yamamoto Y, Kosaka N, Kawamata M, Kelnar K, Bader AG, Brown D, Ochiya T. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 181-7. PMID 19738602 DOI: 10.1038/Mt.2009.207 |
0.565 |
|
2009 |
Li H, Jiang M, Honorio S, Patrawala L, Jeter CR, Calhoun-Davis T, Hayward SW, Tang DG. Methodologies in assaying prostate cancer stem cells. Methods in Molecular Biology (Clifton, N.J.). 568: 85-138. PMID 19582423 DOI: 10.1007/978-1-59745-280-9_7 |
0.747 |
|
2009 |
Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (Dayton, Ohio). 27: 993-1005. PMID 19415763 DOI: 10.1002/Stem.29 |
0.762 |
|
2008 |
Bhatia B, Jiang M, Suraneni M, Patrawala L, Badeaux M, Schneider-Broussard R, Multani AS, Jeter CR, Calhoun-Davis T, Hu L, Hu J, Tsavachidis S, Zhang W, Chang S, Hayward SW, et al. Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. The Journal of Biological Chemistry. 283: 27957-72. PMID 18662989 DOI: 10.1074/Jbc.M803467200 |
0.737 |
|
2008 |
Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG, Slack FJ. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle (Georgetown, Tex.). 7: 759-64. PMID 18344688 DOI: 10.4161/Cc.7.6.5834 |
0.387 |
|
2008 |
Bhatia B, Multani AS, Patrawala L, Chen X, Calhoun-Davis T, Zhou J, Schroeder L, Schneider-Broussard R, Shen J, Pathak S, Chang S, Tang DG. Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT. International Journal of Cancer. Journal International Du Cancer. 122: 1483-95. PMID 18059027 DOI: 10.1002/Ijc.23222 |
0.757 |
|
2007 |
Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Research. 67: 6796-805. PMID 17638891 DOI: 10.1158/0008-5472.Can-07-0490 |
0.787 |
|
2007 |
Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R, Jeter C. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Molecular Carcinogenesis. 46: 1-14. PMID 16921491 DOI: 10.1002/Mc.20255 |
0.757 |
|
2007 |
Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Erratum: Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44+α2β1+ cell population is enriched in tumor-initiating cells (Cancer Research (2007) 67, (6796-6805)) Cancer Research. 67. DOI: 10.1158/0008-5472.Can-67-18-Cor1 |
0.784 |
|
2006 |
Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 25: 1696-708. PMID 16449977 DOI: 10.1038/Sj.Onc.1209327 |
0.742 |
|
2005 |
Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Research. 65: 6207-19. PMID 16024622 DOI: 10.1158/0008-5472.Can-05-0592 |
0.74 |
|
Show low-probability matches. |